National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NRC | NRC HEALTH | 2026-09-17 14:59:52 | 20.88 | -1.22 | -5.52 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRC | 0000070487 | NRC HEALTH | US6373722023 | 549300FQIORB6GZCYT15 | 470634000 | Nasdaq | 8731 | Services-Commercial Physical & Biological Research | 1231 | DE | 1245 Q STREET | LINCOLN | NE | 68508 | UNITED STATES | US | 4024752525 | 1245 Q STREET, LINCOLN, NE, 68508 | 1245 Q STREET, LINCOLN, NE, 68508 | NATIONAL RESEARCH CORP | — | 1981 | Michael D. Hays | 352 | http://nationalresearch.com/ | 194,764,382 | 31,975,649 | 22,119,566 | National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026. | 2026-09-17 20:31:49 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 194,764,382 | -104,633,653 | -34.948 | 22,536,696 | -408,836 | -1.7818 |
| 2024 | 299,398,035 | -231,664,227 | -43.6228 | 22,945,532 | -908,896 | -3.8102 |
| 2023 | 531,062,262 | 87,043,470 | 19.6036 | 23,854,428 | -739,962 | -3.0087 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Helen L. Hrdy | Chief Operating Officer, EVP | 2025 | 400,000 | 826,667 | 1,240,000 | 0 | 8,180 | 2,474,847 |
| Andy Monnich | EVP, Chief Corporate Development Officer | 2025 | 400,000 | 826,667 | 1,240,000 | 0 | 8,150 | 2,474,817 |
| Trent Green | Chief Executive Officer | 2025 | 697,115 | 4,503,333 | 6,755,000 | 0 | 6,452 | 11,961,900 |
| Shane Harrison | Chief Financial Officer | 2025 | 92,308 | 100,000 | 2,287,600 | 0 | 1,192 | 2,481,100 |
| Jason Rau | Executive Vice President | 2025 | 362,308 | 0 | 0 | 249,515 | 7,310 | 619,133 |
| Fiscal Year | Employee Count |
|---|---|
| 2019 | 464 |
| 2018 | 434 |
| 2017 | 430 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 137,390,000 | 143,060,000 | 148,580,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | 74,961,000 | 92,127,000 | 96,060,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 54,805,000 | 44,911,000 | 46,621,000 |
| Operating Expenses | 52,371,000 | 56,933,000 | 56,015,000 |
| Operating Income | 22,590,000 | 35,194,000 | 40,045,000 |
| Net Income | 11,600,000 | 24,783,000 | 30,971,000 |
| Earnings Per Share Basic | 50 | 1.05 | 1.26 |
| Earnings Per Share Diluted | 50 | 1.04 | 1.25 |
| Weighted Average Shares Outstanding Basic | 22,383,000 | 23,703,000 | 24,540,000 |
| Weighted Average Shares Outstanding Diluted | 22,396,000 | 23,743,000 | 24,673,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 4,139,000 | 4,233,000 | 6,653,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 11,108,000 | 11,054,000 | 12,378,000 |
| Inventories | — | — | — |
| Non Trade Receivables | 528,000 | 141,000 | 161,000 |
| Other Assets Current | 520,000 | 692,000 | 940,000 |
| Total Assets Current | 20,209,000 | 19,600,000 | 24,360,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 40,474,000 | 38,269,000 | 28,205,000 |
| Other Assets Non Current | 3,318,000 | 2,713,000 | 3,274,000 |
| Total Assets Non Current | 114,669,000 | 112,939,000 | 98,077,000 |
| Total Assets | 134,878,000 | 132,539,000 | 122,437,000 |
| Accounts Payable | 1,169,000 | 1,194,000 | 1,301,000 |
| Deferred Revenue | 16,201,000 | 15,786,000 | 14,834,000 |
| Short Term Debt | 4,121,000 | 4,842,000 | 7,250,000 |
| Other Liabilities Current | 946,000 | 561,000 | 880,000 |
| Total Liabilities Current | 36,620,000 | 35,858,000 | 36,203,000 |
| Long Term Debt | 75,021,000 | 57,895,000 | 36,787,000 |
| Other Liabilities Non Current | 3,263,000 | 3,652,000 | 3,670,000 |
| Total Liabilities Non Current | 84,268,000 | 65,397,000 | 37,279,000 |
| Total Liabilities | 120,888,000 | 101,255,000 | 73,482,000 |
| Common Stock | 32,000 | 31,000 | 31,000 |
| Retained Earnings | -17,298,000 | -17,064,000 | -30,530,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 13,990,000 | 31,284,000 | 48,955,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 7,624,000 | 6,022,000 | 5,899,000 |
| Share Based Compensation Expense | 3,312,000 | 284,000 | 935,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 53,000 | -1,757,000 | -2,084,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -24,000 | -1,749,000 | 1,767,000 |
| Change In Accounts Payable | 170,000 | -108,000 | 184,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 26,450,000 | 34,625,000 | 38,113,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 10,706,000 | 15,448,000 | 15,779,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -10,706,000 | -20,281,000 | -15,778,000 |
| Tax Withholding For Share Based Compensation | 407,000 | 317,000 | 0 |
| Payments Of Dividends | 11,834,000 | 11,317,000 | 36,317,000 |
| Issuance Of Common Stock | 320,000 | 1,752,000 | 1,825,000 |
| Repurchase Of Common Stock | 20,180,000 | 30,945,000 | 19,099,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 37,003,000 | 49,500,000 | 15,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -15,838,000 | -16,764,000 | -40,707,000 |
| Change In Cash | -94,000 | -2,420,000 | -18,373,000 |
| Cash At End Of Period | 4,139,000 | 4,233,000 | 6,653,000 |
| Income Taxes Paid | — | 8,225,000 | 8,932,000 |
| Interest Paid | 4,485,000 | 2,440,000 | 803,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 50 | 1.05 | 1.26 |
| Price To Earnings Ratio | 0.3754 | 16.8 | 31.3968 |
| Earnings Growth Rate | 4,661.9048 | -16.6667 | -1.5625 |
| Price Earnings To Growth Ratio | 0.0001 | -1.008 | -20.094 |
| Book Value Per Share | 0.625 | 1.3198 | 1.9949 |
| Price To Book Ratio | 30.0307 | 13.3653 | 19.8305 |
| Ebitda | 23,985,000 | 41,625,000 | 46,664,000 |
| Enterprise Value | 495,131,910 | 476,624,920 | 1,008,186,400 |
| Dividend Yield | 0.0282 | 0.0271 | 0.0374 |
| Dividend Payout Ratio | 1.0202 | 0.4566 | 1.1726 |
| Debt To Equity Ratio | 5.657 | 2.0054 | 0.8995 |
| Capital Expenditures | 9,829,000 | 16,086,000 | 16,856,000 |
| Free Cash Flow | 16,621,000 | 18,539,000 | 21,257,000 |
| Return On Equity | 0.8292 | 0.7922 | 0.6326 |
| One Year Beta | 0.7173 | 0.8859 | 0.5152 |
| Three Year Beta | 0.6994 | 0.5971 | 0.5917 |
| Five Year Beta | 0.6511 | 0.9765 | 0.9565 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Wheeler Penny Ann | Director | 2026-06-23 | 7,697 | A | 7,697 |
| NUNNELLY JOHN N | Director | 2026-06-23 | 7,697 | A | 40,363 |
| Lockhart Stephen H | Director | 2026-06-23 | 7,697 | A | 7,697 |
| Bhandari Parul | Director | 2026-06-23 | 7,697 | A | 7,697 |
| Berwick Donald M | Director | 2026-06-23 | 7,697 | A | 7,697 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 2026-06-30 | 1,382,529 | 64,095 | 21.57 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-06-30 | 3,516 | 163 | 21.5706 |
| MERCER GLOBAL ADVISORS INC /ADV | 2026-06-30 | 202,283 | 9,378 | 21.57 |
| Transamerica Financial Advisors, LLC | 2026-06-30 | 130 | 6 | 21.6667 |
| Empowered Funds, LLC | 2026-06-30 | 284,681 | 13,198 | 21.57 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| WisdomTree Trust | 2026-06-30 | WisdomTree U.S. SmallCap Fund | EES | 12,739 | 274,780.23 | 0.0379 |
| WisdomTree Trust | 2026-06-30 | WisdomTree U.S. SmallCap Dividend Fund | DES | 128,096 | 2,763,030.72 | 0.1264 |
| WisdomTree Trust | 2026-06-30 | WisdomTree U.S. High Dividend Fund | DHS | 17,172 | 370,400.04 | 0.0247 |
| WisdomTree Trust | 2026-06-30 | WisdomTree U.S. SmallCap Quality Dividend Growth Fund | DGRS | 48,442 | 1,044,893.94 | 0.2612 |
| VANGUARD VALLEY FORGE FUNDS | 2026-06-30 | INSTITUTIONAL SHARES | VBAIX | 8,513 | 183,625.41 | 0.0003 |